Your browser doesn't support javascript.
loading
Efficacy, tolerability, patient usability, and satisfaction with a 2 mL pre-filled syringe containing secukinumab 300 mg in patients with moderate to severe plaque psoriasis: results from the phase 3 randomized, double-blind, placebo-controlled ALLURE study.
Sigurgeirsson, Bardur; Schäkel, Knut; Hong, Chih-Ho; Effendy, Isaak; Placek, Waldemar; Rich, Phoebe; Keefe, Deborah; Bruin, Gerard; Charef, Pascal; Fu, Rong; Hampele, Isabelle; Patekar, Manmath.
Afiliación
  • Sigurgeirsson B; Department of Dermatology, Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
  • Schäkel K; Department of Dermatology, Heidelberg University Hospital, Heidelberg and Interdisciplinary Center of Chronic Inflammatory Diseases, Heidelberg, Germany.
  • Hong CH; Dr. Chih-Ho Hong Medical Inc., Surrey, Canada.
  • Effendy I; Probity Medical Research, Waterloo, Canada.
  • Placek W; Department of Dermatology and Skin Science, University of British Columbia, Vancouver, Canada.
  • Rich P; Department of Dermatology, Municipal Hospital of Bielefeld, Bielefeld, Germany.
  • Keefe D; Department of Dermatology, Sexually Transmitted Diseases and Clinical Immunology, University of Waria and Mazury Olsztyn, Olsztyn, Poland.
  • Bruin G; Department of Dermatology, Oregon Health and Science University, Portland, OR, USA.
  • Charef P; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Fu R; Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Hampele I; Novartis Pharma AG, Basel, Switzerland.
  • Patekar M; Novartis Institute for Biomedical Research, Shanghai, China.
J Dermatolog Treat ; 33(3): 1718-1726, 2022 May.
Article en En | MEDLINE | ID: mdl-33896356
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Jeringas / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Dermatolog Treat Asunto de la revista: DERMATOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Islandia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Jeringas / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Dermatolog Treat Asunto de la revista: DERMATOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Islandia Pais de publicación: Reino Unido